For instance, Cigna reported a trailing price-to-earnings ratio around 9.1 as referenced by GuruFocus on 06/03/2026, which can be compared with higher multiples often seen at larger diversified peers such as UnitedHealth Group, while Cigna's 52-week trading range from about USD 239.51 to USD 338.89 shows that its current level near USD 272 is below both that recent high and some consensus price targets in the sector as compiled by certain analyst aggregators
Adems, si tienes enfermedades como cirrosis o insuficiencia renal, existe un mayor riesgo de deficiencia
Eur J Gastroenterol Hepatol 24(9):10071011 Smiderle CA, Coral GP, DE CARLI LA, MATTOS AA, MATTOS AZ, Tovo CV (2021) Performace of triglyceride-glucose index on diagnosis and staging of nafld in obese patients
Understanding how B12 works and why injections are often more effective than pills helps you make an informed choice about your health
doi:10.1210/jcem-72-3-730